These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 3503653)

  • 1. Natural inhibitors of complement. III. Inactivation of the complement cascade in vitro by vegetal spices (Ocimum basilicum, Artemisia dracunculus and Thymus vulgaris).
    Gancevici GG; Popescu C
    Arch Roum Pathol Exp Microbiol; 1987; 46(4):321-31. PubMed ID: 3503653
    [No Abstract]   [Full Text] [Related]  

  • 2. [New complement inhibitors; synthetic and natural products].
    Gancevici GG; Popescu C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1985; 30(3):263-75. PubMed ID: 4048755
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-inflammatory drugs and the complement system. A condensation product of metacresolsulfonic acid and formaldehyde prevents instantly the complement activation in vitro.
    Gancevici GG; Popescu C
    Arch Roum Pathol Exp Microbiol; 1989; 48(2):157-62. PubMed ID: 2634368
    [No Abstract]   [Full Text] [Related]  

  • 4. Anticomplementary activity of constituents from the heartwood of Caesalpinia sappan.
    Oh SR; Kim DS; Lee IS; Jung KY; Lee JJ; Lee HK
    Planta Med; 1998 Jun; 64(5):456-8. PubMed ID: 9690348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactions and side reactions to drugs.
    Rother U
    Prog Allergy; 1986; 39():123-33. PubMed ID: 3562461
    [No Abstract]   [Full Text] [Related]  

  • 6. Multimeric tyrosine sulfate acts as an endothelial cell protectant and prevents complement activation in xenotransplantation models.
    Laumonier T; Walpen AJ; Matozan KM; Korchagina EY; Bovin NV; Haeberli A; Mohacsi PJ; Rieben R
    Xenotransplantation; 2004 May; 11(3):262-8. PubMed ID: 15099206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement-inhibiting properties of Apeiba tibourbou.
    Lasure A; Van Poel B; Pieters L; Claeys M; Gupta M; Vanden Berghe D; Vlietinck AJ
    Planta Med; 1994 Jun; 60(3):276-7. PubMed ID: 8073094
    [No Abstract]   [Full Text] [Related]  

  • 8. Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle.
    Pemberton M; Anderson G; Vĕtvicka V; Justus DE; Ross GD
    J Immunol; 1993 Jun; 150(11):5104-13. PubMed ID: 8496606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dextran sulfate acts as an endothelial cell protectant and inhibits human complement and natural killer cell-mediated cytotoxicity against porcine cells.
    Laumonier T; Walpen AJ; Maurus CF; Mohacsi PJ; Matozan KM; Korchagina EY; Bovin NV; Vanhove B; Seebach JD; Rieben R
    Transplantation; 2003 Sep; 76(5):838-43. PubMed ID: 14501864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural inhibitors of complement. II. Isolation of pokeweed complement inhibitor(s) by ion exchange.
    Gancevici GG; Popescu C
    Arch Roum Pathol Exp Microbiol; 1987; 46(1):47-56. PubMed ID: 3324993
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of the alternative pathway of human complement in vitro by a natural microbial product, complestatin.
    Kaneko I; Fearon DT; Austen KF
    J Immunol; 1980 Mar; 124(3):1194-8. PubMed ID: 6898640
    [No Abstract]   [Full Text] [Related]  

  • 12. Lactones from the leaves of Litsea japonica and their anti-complement activity.
    Min BS; Lee SY; Kim JH; Kwon OK; Park BY; An RB; Lee JK; Moon HI; Kim TJ; Kim YH; Joung H; Lee HK
    J Nat Prod; 2003 Oct; 66(10):1388-90. PubMed ID: 14575444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of heparin/protamine complex-induced complement activation by Compstatin in baboons.
    Soulika AM; Khan MM; Hattori T; Bowen FW; Richardson BA; Hack CE; Sahu A; Edmunds LH; Lambris JD
    Clin Immunol; 2000 Sep; 96(3):212-21. PubMed ID: 10964539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of C3 receptors on lymphoid cells with different complement sources.
    Dierich MP; Pellegrino MA; Ferrone S; Reisfeld RA
    J Immunol; 1974 May; 112(5):1766-73. PubMed ID: 4522461
    [No Abstract]   [Full Text] [Related]  

  • 15. The interaction of liposomes with the complement system.
    Szebeni J
    Crit Rev Ther Drug Carrier Syst; 1998; 15(1):57-88. PubMed ID: 9523086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement-inhibiting cucurbitacin glycosides from Picria fel-terrae.
    Huang Y; De Bruyne T; Apers S; Ma Y; Claeys M; Vanden Berghe D; Pieters L; Vlietinck A
    J Nat Prod; 1998 Jun; 61(6):757-61. PubMed ID: 9644059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer research center hotline: complement depletion: use of human C3/cobra venom factor (CVF) chimeric proteins as therapeutic agents.
    Fritzinger DC
    Hawaii Med J; 2005 May; 64(5):133-4, 137. PubMed ID: 15989147
    [No Abstract]   [Full Text] [Related]  

  • 18. Mode of complement activation by acidic heteroglycans from the leaves of Artemisia princeps PAMP.
    Yamada H; Nagai T; Cyong JC; Otsuka Y
    Chem Pharm Bull (Tokyo); 1991 Aug; 39(8):2077-81. PubMed ID: 1797428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro anti-complementary activity of flavonoids from olive (Olea europaea L.) leaves.
    Pieroni A; Heimler D; Pieters L; van Poel B; Vlietinck AJ
    Pharmazie; 1996 Oct; 51(10):765-8. PubMed ID: 8941947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The complement system as a therapeutic target in autoimmunity.
    Holers VM
    Clin Immunol; 2003 Jun; 107(3):140-51. PubMed ID: 12804527
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.